Mazor, Israel

David Katz


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 169(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Katz: Innovator in Drug Delivery Systems

Introduction

David Katz, an innovative inventor based in Mazor, IL, is making strides in the field of medical devices. With a patent to his name, Katz focuses on enhancing drug delivery systems, making significant contributions to the healthcare industry. His work aims to improve patient experiences and outcomes through advanced technology.

Latest Patents

Katz's notable patent focuses on a drug delivery device that incorporates an improved adhesion and attachment system. This innovative system is designed to be positioned between a rigid or semi-rigid device and human skin. The key feature of this device is its ability to reliably adhere to the skin for extended durations. The system comprises a skin-contacting surface that ensures strong adherence while minimizing external stress on the skin, effectively reducing the chances of detachment.

Career Highlights

Currently, David Katz is affiliated with Elan Pharma International Limited, where he leverages his expertise in developing advanced medical technology. His achievements showcase a commitment to innovation in drug delivery methods, bringing practical solutions to the market.

Collaborations

In his professional journey, Katz collaborates with talented coworkers such as Oz Cabiri and Mario Rozanowich, who contribute their skills and knowledge to the projects undertaken at Elan Pharma. This collaborative environment fosters creativity and helps push the boundaries of innovation within the company.

Conclusion

David Katz stands out as a key figure in the realm of drug delivery device innovations. His patented system not only highlights his inventive spirit but also reflects a commitment to improving medical solutions for effective patient care. As he continues his work at Elan Pharma International Limited, his contributions will undoubtedly advance the field and enhance the experiences of patients relying on drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…